What’s on the agenda, you ask?
- The current state of potential cBHT limits, and of APC’s Media Campaign to protect compounded hormones
- Compounding-related legislation in Congress, including provider status
- UPC <795> and <797> updates
- APC’s just-introduced “Urgent Use” legislation
- Upcoming APC meetings and educational opportunities
And more, of course.
District III: Illinois, Indiana, Kentucky, North Carolina, Ohio, South Carolina, Virginia, West Virginia
District IV: Alabama, Arkansas, Florida, Georgia, Mississippi, and Tennessee
District VII: Alaska, Arizona, California, Hawai’i, Idaho, Nevada, Oregon, and Washington.